ArticleJournal of biomedical optics2026
Article in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Real-time photoacoustic imaging with freehand light delivery and augmented reality guidance.Photoacoustics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Significance: Ureteral injuries represent a major concern during a range of surgical procedures, due to the proximity of the ureter to target surgical structures. Intraoperative identification of the ureter is critical to prevent this accidental damage. Aim: We demonstrate the first known Approach: Photoacoustic channel data from the ureters of two swine were acquired using a Vevo F2 ultrasound system and an Opotek Phocus Mobile laser. Images were beamformed using a delay-and-sum algorithm. Photoacoustic image quality was evaluated using contrast, signal-to-noise ratio (SNR), and generalized contrast-to-noise ratio (gCNR) metrics, measured 10 to 80 min after methylene blue injection. Results: Across the 10- to 80-min imaging window, median contrast (3.46-11.43 dB), SNR (2.84-6.99), and gCNR (0.27-0.64) confirmed sustained ureter visibility with methylene blue. Maximum image quality was observed 20- to 30-min after methylene blue injection, with significantly higher contrast, SNR, and gCNR values compared with earlier or later time points ( Conclusions:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.